Astellas Pharma Inc
TSE:4503

Watchlist Manager
Astellas Pharma Inc Logo
Astellas Pharma Inc
TSE:4503
Watchlist
Price: 1 530.5 JPY 0.76% Market Closed
Market Cap: 2.8T JPY
Have any thoughts about
Astellas Pharma Inc?
Write Note

Intrinsic Value

The intrinsic value of one Astellas Pharma Inc stock under the Base Case scenario is 1 755.51 JPY. Compared to the current market price of 1 530.5 JPY, Astellas Pharma Inc is Undervalued by 13%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
1 755.51 JPY
Undervaluation 13%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Astellas Pharma Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for Astellas Pharma Inc cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about Astellas Pharma Inc?
Bearish
Neutral
Bullish

Fundamental Analysis

1 530.5 JPY
+0.76%
+0.76%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Astellas Pharma Inc
JP
Pharmaceuticals
Market Cap
2.7T JPY
IPO
May 16, 1949
Employees
15 455
Japan
Market Cap
2.7T JPY
Industry
Pharmaceuticals
IPO
May 16, 1949
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Astellas Pharma Inc

Provide an overview of the primary business activities
of Astellas Pharma Inc.

What unique competitive advantages
does Astellas Pharma Inc hold over its rivals?

What risks and challenges
does Astellas Pharma Inc face in the near future?

Summarize the latest earnings call
of Astellas Pharma Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Astellas Pharma Inc.

Provide P/S
for Astellas Pharma Inc.

Provide P/E
for Astellas Pharma Inc.

Provide P/OCF
for Astellas Pharma Inc.

Provide P/FCFE
for Astellas Pharma Inc.

Provide P/B
for Astellas Pharma Inc.

Provide EV/S
for Astellas Pharma Inc.

Provide EV/GP
for Astellas Pharma Inc.

Provide EV/EBITDA
for Astellas Pharma Inc.

Provide EV/EBIT
for Astellas Pharma Inc.

Provide EV/OCF
for Astellas Pharma Inc.

Provide EV/FCFF
for Astellas Pharma Inc.

Provide EV/IC
for Astellas Pharma Inc.

Show me price targets
for Astellas Pharma Inc made by professional analysts.

What are the Revenue projections
for Astellas Pharma Inc?

How accurate were the past Revenue estimates
for Astellas Pharma Inc?

What are the Net Income projections
for Astellas Pharma Inc?

How accurate were the past Net Income estimates
for Astellas Pharma Inc?

What are the EPS projections
for Astellas Pharma Inc?

How accurate were the past EPS estimates
for Astellas Pharma Inc?

What are the EBIT projections
for Astellas Pharma Inc?

How accurate were the past EBIT estimates
for Astellas Pharma Inc?

Compare the revenue forecasts
for Astellas Pharma Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Astellas Pharma Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Astellas Pharma Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Astellas Pharma Inc compared to its peers.

Compare the P/E ratios
of Astellas Pharma Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Astellas Pharma Inc with its peers.

Analyze the financial leverage
of Astellas Pharma Inc compared to its main competitors.

Show all profitability ratios
for Astellas Pharma Inc.

Provide ROE
for Astellas Pharma Inc.

Provide ROA
for Astellas Pharma Inc.

Provide ROIC
for Astellas Pharma Inc.

Provide ROCE
for Astellas Pharma Inc.

Provide Gross Margin
for Astellas Pharma Inc.

Provide Operating Margin
for Astellas Pharma Inc.

Provide Net Margin
for Astellas Pharma Inc.

Provide FCF Margin
for Astellas Pharma Inc.

Show all solvency ratios
for Astellas Pharma Inc.

Provide D/E Ratio
for Astellas Pharma Inc.

Provide D/A Ratio
for Astellas Pharma Inc.

Provide Interest Coverage Ratio
for Astellas Pharma Inc.

Provide Altman Z-Score Ratio
for Astellas Pharma Inc.

Provide Quick Ratio
for Astellas Pharma Inc.

Provide Current Ratio
for Astellas Pharma Inc.

Provide Cash Ratio
for Astellas Pharma Inc.

What is the historical Revenue growth
over the last 5 years for Astellas Pharma Inc?

What is the historical Net Income growth
over the last 5 years for Astellas Pharma Inc?

What is the current Free Cash Flow
of Astellas Pharma Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Astellas Pharma Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Astellas Pharma Inc

Current Assets 1.2T
Cash & Short-Term Investments 329.3B
Receivables 570.9B
Other Current Assets 302.9B
Non-Current Assets 2.3T
Long-Term Investments 123B
PP&E 315.3B
Intangibles 1.7T
Other Non-Current Assets 99.8B
Current Liabilities 1.1T
Accounts Payable 161.2B
Other Current Liabilities 932.2B
Non-Current Liabilities 839B
Long-Term Debt 620.2B
Other Non-Current Liabilities 218.8B
Efficiency

Earnings Waterfall
Astellas Pharma Inc

Revenue
1.8T JPY
Cost of Revenue
-323B JPY
Gross Profit
1.4T JPY
Operating Expenses
-1.3T JPY
Operating Income
120.4B JPY
Other Expenses
-65.7B JPY
Net Income
54.7B JPY

Free Cash Flow Analysis
Astellas Pharma Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Astellas Pharma Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
52/100
Profitability
Score

Astellas Pharma Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Astellas Pharma Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
53/100
Solvency
Score

Astellas Pharma Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Astellas Pharma Inc

Wall Street analysts forecast Astellas Pharma Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Astellas Pharma Inc is 1 990.36 JPY with a low forecast of 1 414 JPY and a high forecast of 2 520 JPY.

Lowest
Price Target
1 414 JPY
8% Downside
Average
Price Target
1 990.36 JPY
30% Upside
Highest
Price Target
2 520 JPY
65% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Astellas Pharma Inc?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Astellas Pharma Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

News

Other Videos

See Also

Discover More
What is the Intrinsic Value of one Astellas Pharma Inc stock?

The intrinsic value of one Astellas Pharma Inc stock under the Base Case scenario is 1 755.51 JPY.

Is Astellas Pharma Inc stock undervalued or overvalued?

Compared to the current market price of 1 530.5 JPY, Astellas Pharma Inc is Undervalued by 13%.

Back to Top